Here are some of the most important Web sites, organizations and efforts underway to bring antibodies to bear in the war against Covid-19, as well as general coverage of immunoprevention.

Coronavirus Prevention Network

The COVID-19 Prevention Network (CoVPN) was formed by the National Institute of Allergy and Infectious Diseases (NIAID) at the US National Institutes of Health to respond to the global pandemic. Using the infectious disease expertise of their existing research networks and global partners, NIAID has directed the networks to address the pressing need for vaccines and monoclonal antibodies (mAbs) against SARS-CoV-2.   The site also helps connect people to clinical trials:
For persons without internet access, or who do not feel comfortable with online forms, they can also call our toll-free registry at 866-CVT-1919 (866-288-1919).

For those that are young, healthy and a bit adventurous, is an organization that advocates on behalf of COVID-19 challenge trial volunteers. Human challenge trials deliberately expose participants to infection, in order to study diseases and test vaccines or treatments. They have been used for influenza, malaria, typhoid, dengue fever, and cholera. Researchers are exploring whether human challenge trials could support the development of vaccines and treatments for COVID-19.

CoVIg-19 Plasma Alliance

An unprecedented partnership of the world’s leading plasma companies, spanning plasma collection, development, production, and distribution. Rather than pursue individual research, they are putting public and patient health first by working together to accelerate the development of a potential treatment, improve the chances of success, and increase supply of the potential treatment.

CDC COVID Data Tracker

Get the latest updates and data on COVID-19 here.  The CDC and NIH have funded multiple rapid track development efforts for antibody-based drugs alongside its efforts for vaccines and other therapies.

Global Virus Network

The Global Virus Network is an international organization of prominent virologists around the world involved in addressing the constantly evolving and newly emerging viruses.


Johns Hopkins Coronavirus Resource Center

A comprehensive and authoritative site for information and links on all aspects of the COVID-19 Epidemic.

Antibody Society

An international non-profit supporting antibody-related research and development, the Antibody Society, has  comprehensive coverage of everything that is being conceived, developed and trialed across immunotherapy with antibodies, vaccines and drug therapies.

National COVID-19 Convalescent Plasma Project

A website for:

  • Health care providers who are considering using convalescent plasma to treat patients, either outside of a trial or in the context of a randomized trial
  • Patients who have recovered from COVID-19 infection and are willing to donate plasma
  • Patients with any stage of COVID-19 (or their families) who are considering this treatment
  • Any member of the public interested in learning more about convalescent plasma use currently and in the past (see section on key papers).

In coordination with the U.S. Food and Drug Administration (FDA), the Red Cross is seeking people who are fully recovered from the new coronavirus to sign up to donate plasma to help current COVID-19 patients. People who have fully recovered from COVID-19 have antibodies in their plasma that can attack the virus. This convalescent plasma is being evaluated as treatment for patients with serious or immediately life-threatening COVID-19 infections, or those judged by a healthcare provider to be at high risk of progression to severe or life-threatening disease.
Scroll to top